CoChat

Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health

Open access

The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index; 7 of the 42 sources its claims cite were checked for support.

Abstract

Background: Benzodiazepines and non-benzodiazepine hypnotics (z-drugs) are commonly prescribed for their anxiolytic and hypnotic properties, though they can also be misused. In studies examining the epidemiology of prescription drug misuse, these medication classes are commonly combined, rendering inadequate knowledge of their patterns of misuse. The objective of this study was to characterize the population prevalence, conditional dependence, and sociodemographic and clinical correlates of the misuse of benzodiazepines and z-drugs. Methods: Data from the National Survey on Drug Use and Health from 2015 to 2019 were used to estimate population-level prevalence and characteristics of benzodiazepine and z-drug misuse. Groups were derived based on past-year misuse of benzodiazepines alone, z-drugs alone, or both drug types. Unadjusted regression analyses were used to compare groups on characteristics of interest. Results: prescription or misuse was common; however, only 2% of the population was estimated to have misused a benzodiazepine in the past year, and less than 0.5% misused z-drugs. People who misused only z-drugs were generally older, more likely to have health insurance, more educated, and had less severe psychiatric symptoms. This group was also more likely to report misuse to cope with sleep difficulty. Although concurrent substance use was highly prevalent in all groups, people who misused z-drugs alone generally reported less concurrent substance use than the other groups. Conclusion: The misuse of z-drugs is less common than benzodiazepines, and people who misuse only z-drugs appear to generally have lower clinical severity. Nonetheless, a substantial subgroup of people exposed to z-drugs report concurrent, past-year use of other substances. Further research on z-drug misuse, including consideration of whether it should be grouped with other anxiolytic/hypnotic drugs, is needed.

Overview

CoChat Summary

## TL;DR

Using NSDUH data from 2015–2019 (n = 282,768), this study found that past-year misuse was much less common for z-drugs than for benzodiazepines, but z-drug misuse still affected a notable minority of exposed users. People who misused only z-drugs tended to be older and less clinically severe than those who misused benzodiazepines, while concurrent substance use was common across all groups.

## Key findings

  • In the full population, estimated past-year misuse was 2% for benzodiazepines and <0.4% for z-drugs; among people exposed to these medications, misuse was 17.7% for benzodiazepines and 9.2% for z-drugs.
  • Past-year exposure itself was common: 13.7% of the population used either medication class, including 11.4% who used or misused benzodiazepines and 4% who used or misused z-drugs.
  • Sedative/anxiolytic use disorder was reported by 2.3% of people who used benzodiazepines and 2.1% of people who used z-drugs; among those who misused them, 12.3% of benzodiazepine misusers and 13.6% of z-drug misusers met criteria for a disorder.
  • The combined misuse group had the highest clinical severity: suicidal ideation (24.9%), suicide plan (11%), and suicide attempt (7%), compared with benzodiazepine-only misuse (18.3%, 7.3%, 3.7%) and z-drug-only misuse (10.6%, 3.4%, 0.9%).
  • Concurrent substance use was highest in the combined group, with an estimated mean of 6.03 drugs, versus 4.32 in the benzodiazepine-only group and 3.19 in the z-drug-only group.
  • For z-drug-only misuse, the dominant motive was sleep: over 88% reported this motive; the paper also reports that sleep-motived misuse was more common than in the benzodiazepine-only group (OR = 13.80, 95% CI 9.98–19.08).

## Methods

  • Secondary analysis of the National Survey on Drug Use and Health (NSDUH) from 2015–2019, a U.S. annual multistage probability sample; aggregated sample size was 282,768 participants.
  • Defined three past-year groups based on use/misuse: benzodiazepines only, z-drugs only, and both; examined prevalence of misuse and sedative/anxiolytic use disorder, plus sociodemographic, clinical, other substance use, and motive variables.
  • Used unadjusted regression analyses, including multinomial logistic regression, with survey design accounted for and false discovery rate correction for multiple testing.

## Limitations

  • The authors state the analysis inherits general NSDUH limitations, including inability to generalize to un- or underrepresented groups such as incarcerated and un-housed people, plus sampling biases.
  • The paper notes several variables were not assessed in NSDUH or not available over a past-year timeframe; specifically, this limited examination of co-use of substances, frequency of misuse, and source of prescription medications for misuse.
  • The paper says responses for some outcomes combined tranquilizers and sedatives, making it hard to isolate unique effects of benzodiazepines versus z-drugs; this is especially important for the combined-use group.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2023.1129447

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Estimated prevalence of prescribed use only and misuse of benzodiazepines and z-drugs (in thousands).
FIGURE 1 Estimated prevalence of prescribed use only and misuse of benzodiazepines and z-drugs (in thousands).CC BY · PubMed Central
FIGURE 2 Motives for most recent misuse (modify drug effect refers to attempts to increase or decrease the effects of another substance; dependent refers to physiological dependence). All model effects statistically significant using false discovery rate correction (p ≤ 0.002). BZ, benzodiazepine only group.
FIGURE 2 Motives for most recent misuse (modify drug effect refers to attempts to increase or decrease the effects of another substance; dependent refers to physiological dependence). All model effects statistically significant using false discovery rate correction (p ≤ 0.002). BZ, benzodiazepine only group.CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 0 Not valid · 19 Not checked · 41 Own results and interpretations

28 more claims

Create a free account to see all 65 claims and to verify the 35 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 15

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 5

  1. 2020, 2019 National Survey on Drug Use and Health Detailed Tables.
  2. Hughes, 2016, Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health., NSDUH Data Rev., 9, 1
  3. 1994, Diagnostic and statistical manual of mental disorders.
  4. 2020, 2019 National Survey on Drug Use and Health Public Use File Codebook.
  5. 2020, 2020 National Survey of Drug Use and Health (NSDUH) Releases.

Cited by

See all 38

Metadata

Authors
McHugh, R. K., Votaw, V. R., Trapani, E. W., & McCarthy, M. D.
Affiliations
  • Harvard University (US)
  • University of New Mexico (US)
  • McLean Hospital (US)
Corresponding author
McHugh, R. Kathryn
Venue
Frontiers in Psychiatry
Published
2023-03-09
Volume
14
Pages
1129447-1129447
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4323666238
Cited by
38
References
37
Citations by year
2026: 12 · 2025: 14 · 2024: 11 · 2023: 1
FWCI
9.73
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute on Drug Abuse
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
Z-drugs, benzodiazepine misuse, prescription drug misuse, non-benzodiazepine hypnotics, prevalence, sociodemographic correlates, psychiatric symptoms, sleep disorders, concurrent substance use, National Survey on Drug Use and Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health. https://app.cochat.ai/papers/10.3389/fpsyt.2023.1129447
The paper
McHugh, R. K., Votaw, V. R., Trapani, E. W., & McCarthy, M. D. (2023). Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1129447

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.